A longitudinal study using data from the Alzheimer’s Disease Neuroimaging Initiative found that omega-3 fatty acid supplementation was associated with accelerated cognitive decline in older adults, challenging the common belief that omega-3 universally protects brain health. Participants taking omega-3 supplements showed faster worsening in MMSE, ADAS-Cog13, and CDR-SB scores over time. Interestingly, the association was not explained by classical Alzheimer’s disease pathologies such as amyloid-β accumulation, tau deposition, or gray matter atrophy. Instead, reduced cerebral glucose metabolism on FDG-PET scans—reflecting impaired synaptic and neuronal function in AD-vulnerable brain regions—partially mediated the relationship, accounting for 19% to 41% of the observed cognitive decline. These findings suggest that omega-3 supplementation may adversely affect cerebral synaptic function in some older adults and highlight the need for a more cautious reassessment of its widespread use for cognitive protection. Source: https://www.sciencedirect.com/
In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, complete coronary…
The Fifth Universal Definition of Myocardial Infarction (MI) updates the classification of MI by defining…
The US updated evidence-based recommendations provide clinicians with comprehensive guidance on when to initiate pharmacologic…
In patients with intermediate-high–risk acute pulmonary embolism, catheter-directed thrombolysis with alteplase plus anticoagulation significantly reduced…
In a large randomized trial, atorvastatin 40 mg daily significantly reduced major cardiovascular events by…
In patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM), aficamten significantly improved exercise capacity and patient-reported…
This website uses cookies.